Ultragenyx Pharmaceutical Inc 10-K for FY2025
Ultragenyx Pharmaceutical Inc. (RARE)
10-K
2026-02-18
For: 2025-12-31
View Original
Added on
April 09, 2026
About this 10-K
Ultragenyx Pharmaceutical Inc filed this 10-K on February 18, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $673M
- up 20.2% from $560M a year earlier
- Net loss
- $575M
- compared with a net loss of $569M a year earlier
- Diluted EPS
- -$5.83
- compared with -$6.29 a year earlier